loadpatents
Patent applications and USPTO patent grants for Muto; Susumu.The latest application filed is for "peptide synthesis method".
Patent | Date |
---|---|
Peptide synthesis method Grant 11,420,997 - Suzuki , et al. August 23, 2 | 2022-08-23 |
Peptide synthesis method Grant 11,098,078 - Kono , et al. August 24, 2 | 2021-08-24 |
Peptide Synthesis Method App 20210139532 - SUZUKI; Hideaki ;   et al. | 2021-05-13 |
Peptide Synthesis Method App 20180215782 - KONO; Yusuke ;   et al. | 2018-08-02 |
PAI-1 inhibitor Grant 8,633,245 - Yamaguchi , et al. January 21, 2 | 2014-01-21 |
Inhibitors against the production and release of inflammatory cytokines Grant 8,263,657 - Muto , et al. September 11, 2 | 2012-09-11 |
Inflammatory cytokine release inhibitor Grant 8,097,759 - Muto , et al. January 17, 2 | 2012-01-17 |
Derivative having PPAR agonistic activity Grant 8,097,610 - Itai , et al. January 17, 2 | 2012-01-17 |
Oxazolidinone Derivative Having Inhibitory Activity On 11beta-hydroxysteroid Dehydrogenase Type 1 App 20110294813 - Itai; Akiko ;   et al. | 2011-12-01 |
Carboxilic acid derivatives Grant 8,044,236 - Yamaguchi , et al. October 25, 2 | 2011-10-25 |
Oxazolidinone derivative having inhibitory activity on 11.beta.-hydroxysteroid dehydrogenase type 1 Grant 7,998,992 - Itai , et al. August 16, 2 | 2011-08-16 |
N-phenyloxamide derivatives Grant 7,884,234 - Yamaguchi , et al. February 8, 2 | 2011-02-08 |
Inflammatory Cytokine Release Inhibitor App 20100274051 - MUTO; Susumu ;   et al. | 2010-10-28 |
Heterocyclic Derivative Having Inhibitory Activity On Type-i 11 Data-hydroxysteroid Dehydrogenase App 20100234363 - Itai; Akiko ;   et al. | 2010-09-16 |
Oxazolidinone Derivative Having Inhibitory Activity On 11beta-hydroxysteroid Dehydrogenase Type 1 App 20100113448 - Itai; Akiko ;   et al. | 2010-05-06 |
O-substituted Hydroxyaryl Derivatives App 20100113770 - MUTO; Susumu ;   et al. | 2010-05-06 |
Antiallergic agents Grant 7,700,655 - Muto , et al. April 20, 2 | 2010-04-20 |
N-(3,4-disubstituted phenyl) salicylamide derivatives Grant 7,671,058 - Tokuyama , et al. March 2, 2 | 2010-03-02 |
Pai-1 Inhibitor App 20090312315 - Yamaguchi; Youichi ;   et al. | 2009-12-17 |
O-substituted hydroxyaryl derivatives Grant 7,626,042 - Muto , et al. December 1, 2 | 2009-12-01 |
Derivative having ppar agonistic activity App 20090286974 - Itai; Akiko ;   et al. | 2009-11-19 |
Amide derivatives Grant 7,598,418 - Muto , et al. October 6, 2 | 2009-10-06 |
Inhibitor Of Pai-1 Production App 20090239868 - Muto; Susumu ;   et al. | 2009-09-24 |
N-Phenyloxamide derivatives App 20090215899 - YAMAGUCHI; Youichi ;   et al. | 2009-08-27 |
Inflammatory Cytokine Release Inhibitor App 20090192122 - MUTO; Susumu ;   et al. | 2009-07-30 |
Sulfonamide derivatives Grant 7,547,716 - Muto , et al. June 16, 2 | 2009-06-16 |
Inflammatory Cytokine Release Inhibitor App 20080318956 - MUTO; Susumu ;   et al. | 2008-12-25 |
Inhibitors against activation of NF-kappaB App 20080311074 - MUTO; Susumu ;   et al. | 2008-12-18 |
Carboxilic acid derivatives App 20080275116 - YAMAGUCHI; Youichi ;   et al. | 2008-11-06 |
Inflammatory Cytokine Release Inhibitor App 20080249071 - MUTO; Susumu ;   et al. | 2008-10-09 |
N-Phenyloxamide derivatives App 20080249175 - YAMAGUCHI; Youichi ;   et al. | 2008-10-09 |
Medicament For Treatment Of Neurodegenerative Diseases App 20080234233 - MUTO; Susumu ;   et al. | 2008-09-25 |
N-(3,4-disubstituted phenyl) salicylamide derivatives App 20080227784 - TOKUYAMA; Ryukou ;   et al. | 2008-09-18 |
Coumarin derivative Grant 7,411,076 - Muto , et al. August 12, 2 | 2008-08-12 |
Antiallergic Agents App 20080090779 - Muto; Susumu ;   et al. | 2008-04-17 |
Plasminogen Activator Inhibitor-1 Inhibitor App 20070276011 - Muto; Susumu ;   et al. | 2007-11-29 |
Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation App 20070254956 - Shudo; Koichi ;   et al. | 2007-11-01 |
Antiallergic agents App 20070185059 - Muto; Susumu ;   et al. | 2007-08-09 |
Antiallergic agents App 20070185110 - Muto; Susumu ;   et al. | 2007-08-09 |
Medicament for treatment of dermal pigmentation App 20070042997 - Itai; Akiko ;   et al. | 2007-02-22 |
Quinazolin-4-one derivatives App 20060229324 - Itai; Akiko ;   et al. | 2006-10-12 |
Antiallergic App 20060122243 - Muto; Susumu ;   et al. | 2006-06-08 |
Medicament for treatment of diabetes App 20060111409 - Muto; Susumu ;   et al. | 2006-05-25 |
Inhibitors against the activation of ap-1 and nfat App 20060100257 - Muto; Susumu ;   et al. | 2006-05-11 |
O-substituted hydroxyaryl derivatives App 20060094718 - Muto; Susumu ;   et al. | 2006-05-04 |
Nf-kb activation inhibitors App 20060089395 - Muto; Susumu ;   et al. | 2006-04-27 |
Remedies for neurodegenerative diseases App 20060035944 - Muto; Susumu ;   et al. | 2006-02-16 |
Immunity-related protein kinase inhibitors App 20060019958 - Muto; Susumu ;   et al. | 2006-01-26 |
Medicament for treatment of cancer App 20060014811 - Muto; Susumu ;   et al. | 2006-01-19 |
Amide derivatives App 20050215645 - Muto, Susumu ;   et al. | 2005-09-29 |
Coumarin derivative App 20050054717 - Muto, Susumu ;   et al. | 2005-03-10 |
Inhibitors against the production and release of inflammatory cytokines App 20040259877 - Muto, Susumu ;   et al. | 2004-12-23 |
Sulfonamide derivatives App 20040234622 - Muto, Susumu ;   et al. | 2004-11-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.